BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11263677)

  • 41. Discriminative stimulus effects of a centrally administered, delta-opioid peptide (D-Pen2-D-Pen5-enkephalin) in pigeons.
    Jewett DC; Mosberg HI; Woods JH
    Psychopharmacology (Berl); 1996 Oct; 127(3):225-30. PubMed ID: 8912400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
    Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
    Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioid peptide receptor studies. 8. One of the mouse brain deltaNCX binding sites is similar to the cloned mouse opioid delta receptor: further evidence for heterogeneity of delta opioid receptors.
    Xu H; Lu YF; Partilla JS; Pinto J; Calderon SN; Matecka D; Rice KC; Lai J; Porreca F; Ananthan S; Rothman RB
    Peptides; 1998; 19(2):343-50. PubMed ID: 9493867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor.
    Parkhill AL; Bidlack JM
    Eur J Pharmacol; 2002 Sep; 451(3):257-64. PubMed ID: 12242086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of competitive and noncompetitive antagonists of the N-methyl-D-aspartate receptor on the analgesic action of delta 1- and delta 2-opioid receptor agonists in mice.
    Bharagava HN; Zhao GM
    Br J Pharmacol; 1996 Dec; 119(8):1586-90. PubMed ID: 8982505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.
    Negri L; Lattanzi R; Borsodi A; Toth G; Salvadori S
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):203-11. PubMed ID: 10355826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
    Contreras PC; Tam L; Drower E; Rafferty MF
    Brain Res; 1993 Feb; 604(1-2):160-4. PubMed ID: 8384509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
    Barrett RW; Vaught JL
    Life Sci; 1983 Dec; 33(24):2439-48. PubMed ID: 6316063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies.
    Kitchen I; Leslie FM; Kelly M; Barnes R; Crook TJ; Hill RG; Borsodi A; Toth G; Melchiorri P; Negri L
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1597-607. PubMed ID: 8531134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.
    Bhargava HN; Gulati A; Rahmani NH
    Eur J Pharmacol; 1991 Sep; 202(3):403-8. PubMed ID: 1660817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin.
    Vaughn LK; Knapp RJ; Toth G; Wan YP; Hruby VJ; Yamamura HI
    Life Sci; 1989; 45(11):1001-8. PubMed ID: 2552241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand.
    McDowell J; Kitchen I
    Eur J Pharmacol; 1986 Sep; 128(3):287-9. PubMed ID: 3024998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
    Wang XM; Yan JQ; Zhang KM; Mokha SS
    Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
    Portoghese PS; Sultana M; Nagase H; Takemori AE
    Eur J Pharmacol; 1992 Jul; 218(1):195-6. PubMed ID: 1327826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoradiographic evidence for decrease in binding of mu- and delta-opioid receptors after subchronic [D-Ala2,D-Leu5]enkephalin treatment in rats.
    Tao PL; Seybold VS; Loh HH
    Eur J Pharmacol; 1993 Feb; 231(2):145-9. PubMed ID: 8384111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions between angiotensin II and delta opioid receptor subtype agonists upon water intake in rats.
    Yu WZ; Bodnar RJ
    Peptides; 1997; 18(2):241-5. PubMed ID: 9149296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic naltrexone differentially affects supraspinal delta-opioid receptor-mediated antinociception.
    Kest B; Lee CE; Jenab S; Kao B; Inturrisi CE
    Eur J Pharmacol; 1998 Mar; 345(1):47-53. PubMed ID: 9593593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of functional opioid delta receptors in a luteinizing hormone-releasing hormone-producing neuronal cell line.
    Maggi R; Pimpinelli F; Martini L; Piva F
    Endocrinology; 1995 Jan; 136(1):289-95. PubMed ID: 7828543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.